However, as per the BEYOND VIII trial, a higher insulin starting dose of 0.3 U/kg/day was equivalent, in terms of safety, to the standard starting dose of 0.2 U/kg/day among overweight/obese people with T2DM, and self-monitored FBG goals were attained earlier with the higher dose vs
This could translate into price cuts of up to 6070% at launch, and potentially even deeper reductions over time
This product is gluten free.
Autoinjectors may be suitable for projects that require: Fixed-dose delivery Fewer user steps Hidden needle design Push-button or push-on-skin activation A more guided home-use experience A strong focus on patient confidence Differentiated premium device positioning However, an autoinjector is not always the best answer
For Immunotec, California represents tremendous potential for the continued growth and evolution of the global MLM industry